GB1537635A - 15,16-dihydroxyprostaglandins - Google Patents

15,16-dihydroxyprostaglandins

Info

Publication number
GB1537635A
GB1537635A GB48569/77A GB4856977A GB1537635A GB 1537635 A GB1537635 A GB 1537635A GB 48569/77 A GB48569/77 A GB 48569/77A GB 4856977 A GB4856977 A GB 4856977A GB 1537635 A GB1537635 A GB 1537635A
Authority
GB
United Kingdom
Prior art keywords
dihydroxyprostaglandins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB48569/77A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GD Searle LLC
Original Assignee
GD Searle LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GD Searle LLC filed Critical GD Searle LLC
Publication of GB1537635A publication Critical patent/GB1537635A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB48569/77A 1976-11-22 1977-11-22 15,16-dihydroxyprostaglandins Expired GB1537635A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/744,070 US4064350A (en) 1976-11-22 1976-11-22 15,16-Dihydroxyprostaglandins

Publications (1)

Publication Number Publication Date
GB1537635A true GB1537635A (en) 1979-01-04

Family

ID=24991309

Family Applications (1)

Application Number Title Priority Date Filing Date
GB48569/77A Expired GB1537635A (en) 1976-11-22 1977-11-22 15,16-dihydroxyprostaglandins

Country Status (7)

Country Link
US (1) US4064350A (enExample)
JP (1) JPS5365853A (enExample)
AU (1) AU518594B2 (enExample)
CA (1) CA1088933A (enExample)
DE (1) DE2751920A1 (enExample)
FR (1) FR2371426A1 (enExample)
GB (1) GB1537635A (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4194055A (en) * 1976-03-03 1980-03-18 American Cyanamid Company 15,16-dioxy prostenoic acids and esters
US4165331A (en) * 1977-03-30 1979-08-21 American Cyanamid Company 11-(2-Hydroxyethylthio)prostenoic acid E series derivatives
US4235797A (en) * 1977-12-08 1980-11-25 American Cyanamid Company Silyl vinyl esters
IT1162731B (it) * 1979-04-10 1987-04-01 Lepetit Spa 16-metil-16-metossi-5,6-diidro-prosta-glandine della serie e1 ad attivita'antisecretoria
GB8512344D0 (en) * 1985-05-15 1985-06-19 May & Baker Ltd Compositions of matter

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS518248A (en) * 1974-07-09 1976-01-23 Yamanouchi Pharma Co Ltd Shinkina 11*15*166 torihidorokishi 99 okisoopurosutajensanno goseiho
GB1538871A (en) * 1975-01-24 1979-01-24 Lepetit Spa Prostaglandins

Also Published As

Publication number Publication date
FR2371426B1 (enExample) 1981-01-23
CA1088933A (en) 1980-11-04
AU3079477A (en) 1979-05-31
AU518594B2 (en) 1981-10-08
JPS5365853A (en) 1978-06-12
US4064350A (en) 1977-12-20
FR2371426A1 (fr) 1978-06-16
DE2751920A1 (de) 1978-05-24

Similar Documents

Publication Publication Date Title
PH13932A (en) 1,2,3,4-tetrahydro-napthalenes
ZA77587B (en) 2-piperazinyl-6,7-dimethoxyquinazolines
GB1524917A (en) Gona-1,9(10)-dienes
NZ183143A (en) 2-aminoakyl-1,2-benzisothiazol 3-anes
GB1542361A (en) 1,4-benzo-dioxan derivatives
GB1542569A (en) 2-substituted-15-heteroaryl-16,17,18,19,20-pentanor-prostaglandins
GB1556569A (en) 1,5-disubstituted - 2 - pyrrolidones
ZA773958B (en) 2,6-methano-2h-1-benzoxocins
PH14105A (en) 1,2,3-thiadiazol-5-yl-ureas
AU2468877A (en) 1,4 -dicyanobytene
ZA774515B (en) O-ethyl-s-n-propyl-o-2,2,2-trihaloethylphosphorothiolates(or thionothiolates)
GB1537635A (en) 15,16-dihydroxyprostaglandins
HK36785A (en) 1-amino-alkyl-3,4-diphenyl-1h-pyrazoles
GB1538368A (en) 1,3,4,6-tetrathia and tetraselena-2,5-dihetero-pentalene compounds
KE3185A (en) 2,3 dihydro-2-oxo-3-benzo (b) thiophene-carboxamides
IL53527A (en) N1-chloro-3,5-dinitrosulfanilamides
NZ184082A (en) 1-benzothiazol-2yl-1,3-imidazolidin-2-ones
GB1547729A (en) 1-phenyl-4-acetoxy-1,2-dihydroquinolin-2-ones
GB1554049A (en) 2-decarboxy-2-hydroxymethyl-13,14-didehydroprostaglandins
AU3191777A (en) 1,4-oxathianes
AU3178777A (en) Substituted 4,5-dihydroxy-imidazolidine-2-thiones
GB1546347A (en) 5,11-diazatetracyclo-(6.2.2.02,7 04,9)-dodecanes
ZA774088B (en) 2,5-dichloro-4-bromphenylazo-4-chloro-phenyl-sulphide
GB1554045A (en) 13,14-didehydroprostaglandins
PL187575A1 (en) Sposob otrzymywania pochodnych 3,4-dwuhydro-2h-1,3-benzoksazynotionu

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee